Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Cardiology

Journal Scan / Research · May 10, 2013

Apixaban Superior to Warfarin for Prevention of Thromboembolic Events

Circulation

 

Additional Info

Disclosure statements are available on the authors' profiles:

Circulation
Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted INR Control for Stroke Prevention in Atrial Fibrillation
Circulation 2013 May 02;[EPub Ahead of Print], L Wallentin, RD Lopes, M Hanna, L Thomas, A Hellkamp, S Nepal, EM Hylek, SM Al-Khatib, JH Alexander, M Alings, J Amerena, J Ansell, P Aylward, J Bartunek, P Commerford, R De Caterina, C Erol, V-P Harjola, C Held, J Horowitz, K Huber, S Husted, M Keltai, F Lanas, L Lisheng, JJV McMurray, B-H Oh, M Rosenqvist, W Ruzyllo, PG Steg, D Vinereanu, D Xavier, CB Granger

Further Reading